Uncategorized
FDA starts 2017 with ophthalmic approvals, NDAs
The first quarter of 2017 saw new developments at the FDA for many ophthalmic drug candidates or technological developments. Here are the top five most-read FDA news stories on Healio.com/OSN this quarter: